Jun‐Tao Tan

ORCID: 0009-0004-9377-647X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Esophageal Cancer Research and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Electrolyte and hormonal disorders
  • Liver Disease Diagnosis and Treatment
  • Hemodynamic Monitoring and Therapy
  • Anesthesia and Neurotoxicity Research
  • Inflammatory mediators and NSAID effects
  • Cancer Immunotherapy and Biomarkers
  • Cardiac, Anesthesia and Surgical Outcomes
  • Click Chemistry and Applications
  • Macrophage Migration Inhibitory Factor
  • Eicosanoids and Hypertension Pharmacology
  • Gastric Cancer Management and Outcomes
  • Intensive Care Unit Cognitive Disorders
  • Anesthesia and Sedative Agents
  • Pharmacogenetics and Drug Metabolism
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Immunotherapy and Immune Responses
  • Nuclear Receptors and Signaling
  • Esophageal and GI Pathology
  • Sepsis Diagnosis and Treatment

University of South China
2024

Hebei Medical University
2019-2020

Fourth Hospital of Hebei Medical University
2019-2020

Tumor Hospital of Guangxi Medical University
2015-2016

The suitability of hepatic resection for older patients remains controversial. This study aimed to investigate whether age influences overall survival with hepatocellular carcinoma (HCC) after resection.Records 1,132 HCC were retrospectively reviewed. Overall (OS) was compared between younger and based on five cut-off ages (30, 40, 50, 60, 70 years).Across all patients, OS 89.7% at 1 year, 67.7% 3 years, 47.7% 5 years. similar (all P > 0.1), but marginally lower among >70 years old than...

10.1002/jso.24434 article EN Journal of Surgical Oncology 2016-09-16

Background: Iron homeostasis disorder and neuroinflammation are the most commonly known factors that promote occurrence development of cognitive impairment in people. Dexmedetomidine has an anti-inflammatory effect, it reduces incidence postoperative dysfunction. Therefore, aim this study is to verify whether dexmedetomidine could improve lipopolysaccharide-induced iron aged mice, show neuroprotective effect. Methods: First part, forty 12 month old male Kunming(KM) mice were divided into...

10.2174/1567202617666200217105109 article EN Current Neurovascular Research 2020-02-17

This study aims to evaluate the effect of neoadjuvant chemoradiotherapy (NCRT) on perioperative immune function during surgery treat resectable locally advanced esophageal cancer. Records were retrospectively analyzed for 220 patients with cancer, whom 112 received alone and 98 NCRT plus surgery. The two groups compared in terms proportions CD3+, CD4+, CD8+, natural kill (NK) cells, as well ratio CD4+ CD8+ cells. These measurements made using flow cytometry preoperative day 1 postoperative...

10.1111/dote.12486 article EN Diseases of the Esophagus 2016-10-01

NR4a1 has been demonstrated to exert a protective role in various chronic inflammatory disease. The underlying mechanism yet be clarified. This research aimed explore the anti-inflammatory of NR4a1on macrophage through bioinformatics analysis and further verified by series experiments. In this study, GSMs (GEO samples) that LPS(lipopolysaccharide) treated derived from wild type knockout mice were extracted GSE68167 gene expression profiles Gene Expression Omnibus (GEO) database. DEGs...

10.22541/au.170663688.87732391/v1 preprint EN Authorea (Authorea) 2024-01-30

e15595 Background: The suitability of hepatic resection for older patients remains controversial. This study aimed to investigate whether age influences overall survival with hepatocellular carcinoma (HCC) after resection. Methods: Records 1,132 HCC were retrospectively reviewed. Overall (OS) was compared between younger and based on five cut-off ages (30, 40, 50, 60, 70 years). Results: Across all patients, OS 89.7 % at 1 year, 67.7 3 years, 47.7% 5 years. similar (all P > 0.1), but...

10.1200/jco.2016.34.15_suppl.e15595 article EN Journal of Clinical Oncology 2016-05-20
Coming Soon ...